|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/31/14 MusclePharm Corp 10-Q/A 6/30/14 92:9M Toppan Merrill/FA |
Document/Exhibit Description Pages Size
1: 10-Q/A Amendment to Quarterly Report HTML 356K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 31K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 31K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
62: R1 Document And Entity Information HTML 49K
49: R2 Consolidated Balance Sheets HTML 137K
60: R3 Consolidated Balance Sheets [Parenthetical] HTML 49K
64: R4 Consolidated Statements of Operations HTML 111K
84: R5 Consolidated Statements of Cash Flows HTML 157K
51: R6 Nature of Operations and Basis of Presentation HTML 32K
59: R7 Summary of Significant Accounting Policies HTML 70K
44: R8 Composition of Certain Financial Statement HTML 154K
Captions
34: R9 Concentrations HTML 68K
85: R10 Financial Instruments HTML 46K
66: R11 Debt HTML 54K
65: R12 Derivative Liabilities HTML 35K
71: R13 Restricted Stock Units HTML 36K
72: R14 Stockholders' Equity HTML 114K
69: R15 Commitments, Contingencies and Other Matters HTML 71K
73: R16 Defined Contribution Plan HTML 30K
61: R17 Related Party Transactions HTML 35K
63: R18 Endorsement Agreement HTML 29K
68: R19 Biozone Acquisition HTML 122K
92: R20 Intangible Assets HTML 66K
80: R21 Restatement of June 30, 2014 Unaudited HTML 118K
Consolidated Financial Statements
55: R22 Subsequent Events HTML 31K
67: R23 Summary of Significant Accounting Policies HTML 139K
(Policies)
57: R24 Concentrations (Tables) HTML 68K
25: R25 Composition of Certain Financial Statement HTML 164K
Captions (Tables)
81: R26 Financial Instruments (Tables) HTML 40K
88: R27 Debt (Tables) HTML 51K
39: R28 Derivative Liabilities (Tables) HTML 32K
38: R29 Stockholders' Equity (Tables) HTML 108K
42: R30 Committments, Contingencies and Other Matters HTML 65K
(Tables)
43: R31 Biozone Acquisition (Tables) HTML 116K
45: R32 Intangible Assets (Tables) HTML 67K
19: R33 Restatement of June 30, 2014 Unaudited HTML 113K
Consolidated Financial Statements (Tables)
78: R34 Composition of Certain Financial Statement HTML 35K
Captions (Details)
53: R35 Composition of Certain Financial Statement HTML 39K
Captions (Details 1)
56: R36 Composition of Certain Financial Statement HTML 55K
Captions (Details 2)
29: R37 Composition of Certain Financial Statement HTML 33K
Captions (Details 3)
91: R38 Composition of Certain Financial Statement HTML 32K
Captions (Details 5)
12: R39 Composition of Certain Financial Statement HTML 51K
Captions (Details 4)
46: R40 Composition of Certain Financial Statement HTML 47K
Captions (Details 6)
83: R41 Composition of Certain Financial Statement HTML 34K
Captions (Details 7)
27: R42 Composition of Certain Financial Statement HTML 35K
Captions (Details 8)
37: R43 Composition of Certain Financial Statement HTML 28K
Captions (Details Textual)
41: R44 Concentrations (Details) HTML 33K
50: R45 Concentrations (Details 1) HTML 33K
18: R46 Concentrations (Details 2) HTML 30K
33: R47 Financial Instruments (Details) HTML 41K
14: R48 Financial Instruments (Details Textual) HTML 26K
82: R49 Debt (Details) HTML 44K
26: R50 Debt (Details 1) HTML 30K
79: R51 Debt (Details 2) HTML 30K
30: R52 Debt (Details Textual) HTML 47K
47: R53 Derivative Liabilities (Details) HTML 34K
13: R54 Derivative Liabilities (Details Textual) HTML 30K
17: R55 Restricted Stock Units (Details Textual) HTML 71K
40: R56 Stockholders' Equity (Details) HTML 55K
21: R57 Stockholders' Equity (Details 1) HTML 30K
86: R58 Stockholders' Equity (Details 2) HTML 48K
52: R59 Stockholders' Equity (Details 3) HTML 53K
70: R60 Stockholders' Equity (Details Textual) HTML 41K
32: R61 Commitments, Contingencies and Other Matters HTML 45K
(Details)
35: R62 Commitments, Contingencies and Other Matters HTML 41K
(Details 1)
77: R63 Commitments, Contingencies and Other Matters HTML 40K
(Details 2)
75: R64 Commitments, Contingencies and Other Matters HTML 53K
(Details Textual)
54: R65 Defined Contribution Plan (Details Textual) HTML 29K
76: R66 Related Party Transactions (Details Textual) HTML 51K
31: R67 Endorsement Agreement (Details Textual) HTML 28K
58: R68 Biozone Acquisition (Details) HTML 63K
87: R69 Biozone Acquisition (Details 1) HTML 32K
16: R70 Biozone Acquisition (Details 2) HTML 42K
24: R71 Biozone Acquisition (Details Textual) HTML 36K
48: R72 Intangible Assets (Details) HTML 43K
20: R73 Intangible Assets (Details 1) HTML 41K
90: R74 Intangible Assets (Details Textual) HTML 28K
28: R75 Restatement of June 30, 2014 Unaudited HTML 113K
Consolidated Financial Statements (Details)
22: R76 Restatement of June 30, 2014 Unaudited HTML 32K
Consolidated Financial Statements (Details
Textual)
23: R77 Subsequent Events (Details Textual) HTML 39K
89: XML IDEA XML File -- Filing Summary XML 136K
15: EXCEL IDEA Workbook of Financial Reports XLSX 190K
36: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.52M
6: EX-101.INS XBRL Instance -- mslp-20140630 XML 2.06M
8: EX-101.CAL XBRL Calculations -- mslp-20140630_cal XML 220K
9: EX-101.DEF XBRL Definitions -- mslp-20140630_def XML 1.09M
10: EX-101.LAB XBRL Labels -- mslp-20140630_lab XML 1.27M
11: EX-101.PRE XBRL Presentations -- mslp-20140630_pre XML 1.22M
7: EX-101.SCH XBRL Schema -- mslp-20140630 XSD 230K
74: ZIP XBRL Zipped Folder -- 0001144204-14-064325-xbrl Zip 191K
 | Download this zipped .zip folder |
| Files: | mslp-20140630.xml mslp-20140630_cal.xml mslp-20140630_def.xml mslp-20140630_lab.xml mslp-20140630_pre.xml mslp-20140630.xsd |